SCHEDULE 13G: Red Tree Venture Fund Discloses 6.2% Passive Stake in CeriBell, Inc.
Beneficial Ownership Disclosure
Red Tree Venture Fund and its affiliates have disclosed a passive beneficial ownership of 6.2% in CeriBell, Inc., as detailed in a recent Schedule 13G filing with the SEC.
Summary
- Red Tree GP, LLC, Red Tree Venture Fund, L.P., Red Tree Venture Fund SPV II, LLC, and Heath Lukatch (collectively, the "Reporting Persons") have filed a Schedule 13G.
- The Reporting Persons collectively beneficially own 2,205,661 shares of CeriBell, Inc.'s common stock.
- This ownership represents 6.2% of CeriBell, Inc.'s total outstanding common stock.
- The beneficial ownership was calculated as of December 31, 2024.
- The percentage is based on 35,824,244 shares of CeriBell, Inc. common stock outstanding as of November 11, 2024, as reported in the Issuer's Form 10-Q.
- Red Tree Venture Fund, L.P. directly holds 2,031,565 shares, accounting for 5.7% of the class.
- Red Tree Venture Fund SPV II, LLC directly holds 174,096 shares, accounting for 0.5% of the class.
- Red Tree GP, LLC serves as the general partner of Red Tree Venture Fund, L.P. and the manager of Red Tree Venture Fund SPV II, LLC.
- Heath Lukatch, PhD, is the managing director of Red Tree GP, LLC.
- All Reporting Persons possess shared voting and shared dispositive power over the beneficially owned shares.
Sentiment
Score: 6
Explanation: The filing indicates a significant passive investment by a venture fund, which can be viewed as a positive signal of investor confidence in CeriBell, Inc. However, as a beneficial ownership disclosure, it does not provide operational or financial performance details to warrant a higher sentiment score.
Positives
- The disclosure of a significant passive stake by Red Tree Venture Fund, a venture capital firm, may signal investor confidence in CeriBell, Inc.'s long-term potential.
- The collective beneficial ownership of 6.2% by the Red Tree entities and Heath Lukatch establishes them as a notable shareholder group in CeriBell, Inc.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from CeriBell, Inc. or the reporting persons regarding the company's future performance.
Industry Context
This filing indicates an investment by a venture capital fund in CeriBell, Inc., which is a common occurrence in sectors like biotechnology or medical devices, where venture capital plays a crucial role in funding and growth. The filing itself does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The disclosure provides transparency regarding a significant institutional ownership stake, which can influence market perception and potentially the company's share price.
Key Dates
| Date | Description |
|---|---|
| 2024-11-11 | Date as of which 35,824,244 shares of CeriBell, Inc. common stock were reported outstanding in the Issuer's Form 10-Q. |
| 2024-12-31 | Date of the event which required the filing of this Schedule 13G (beneficial ownership threshold). |
| 2025-02-14 | Date the Schedule 13G was signed and filed with the SEC. |
Keywords
CeriBell Inc., Schedule 13G, Red Tree Venture Fund, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Heath Lukatch
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.